Category: publisher error

BioMed Central retracts study it published twice while acquiring journal

jdmdYesterday, we wrote about the retraction of a paper that ended up published despite the fact that peer reviewers had recommended rejecting it. Today, we have the (short) tale of a paper retracted because the publisher posted it a second time while they were buying acquiring the journal where it appeared.

Here’s the notice for “The association between depression, socio-economic factors and dietary intake in mothers having primary school children living in Rey, South of Tehran, Iran,” published in the Journal of Diabetes & Metabolic Diseases: Continue reading BioMed Central retracts study it published twice while acquiring journal

Editor inadvertently spurns reviewers; retraction ensues

jvmacoverThe Journal of Multivariate Analysis has retracted a paper it was never meant to publish — a problem, it seems, of multivariate analyses.

The article, titled “Regression estimation with locally stationary long-memory errors,” came from a pair of statisticians in Chile, Wildredo Palma and Guillermo Ferreira.

It appears that the article did not pass muster with the reviewers, but that the editor somehow missed the message. As the retraction notice explains: Continue reading Editor inadvertently spurns reviewers; retraction ensues

Oops: Math journal retracts paper accepted by “accidental administrative error”

jmaaMath journal editors can add — but they can also subtract.

That’s what happened to a 2012 paper in the Journal of Mathematical Analysis and Applications (JMAA), “On the fractional Ostrowski inequality with uncertainty.”

Here’s the notice: Continue reading Oops: Math journal retracts paper accepted by “accidental administrative error”

Look ma, no guidelines! Paper on unpublished fetal surgery recommendations retracted

clinperinatcoverClinics in Perinatology has a rather intriguing retraction.

The paper in question was a June 2012 review by a group of researchers at the University of California, San Francisco’s division of pediatric surgery, titled “Maternal-Fetal Surgery:  History and General Considerations.”

According to the retraction notice: Continue reading Look ma, no guidelines! Paper on unpublished fetal surgery recommendations retracted

Failure at System — systems failure? — leads to duplicate publication, retraction

systemcoverThe journal System evidently needs a new one — at least when it comes to production.

The publication has been forced to retract an article that it published twice — in the same issue.

Here’s what happened: Continue reading Failure at System — systems failure? — leads to duplicate publication, retraction

Journal “mistake” forces removal of toxicology study by leading scientist

We’ve seen this movie before: Researchers present a study at a scientific meeting, then learn to their surprise (and, sometimes, chagrin) that a journal has published the data in a supplement or other edition.

That’s the case with a group of UK scientists whose abstract for a meeting of the British Toxicology Society wound up in the journal Toxicology — only to be expunged when they complained.

The work was titled “Molecular mechanisms involved in resistance of CLL cells towards ABT-737, a specific BCL-2 inhibitor.” Gerald Cohen, of the University of Leicester, who led the study, told us: Continue reading Journal “mistake” forces removal of toxicology study by leading scientist

Eighteen years later, derm journal retracts overlapping article, citing editorial error

Eighteen years ago, the Journal of Dermatology published an article, “A sulfated proteoglycan as a novel ligand for CD44,” by a group of Japanese researchers (the journal is the official periodical of the Japanese Dermatological Society).

The JoD is now retracting that paper because it overlaps with another article by the same group, published a few months earlier in a different journal.

Here’s the notice (behind a pay wall — tsk, tsk, Wiley): Continue reading Eighteen years later, derm journal retracts overlapping article, citing editorial error

What happens when a correction is retracted?

Seyed Rasoul Mousavi, assistant professor in the department of electrical and computer engineering at the Isfahan University of Technology in Khomeynīshahr, Iran, has been working on a way to help biologists assemble genomes with as little information as possible.

Last year, Mousavi submitted a manuscript to the Journal of Theoretical Biology, received acceptance after peer review, and got proofs back to edit.

For technical reasons, Mousavi says his corrections didn’t make it into the final article published on Jan. 12, so the publishers issued a separate corrigendum with the editorial changes. Then, on Feb. 8, the publishers retracted the corrigendum that accompanied the original article. The retraction of the corrigendum reads: Continue reading What happens when a correction is retracted?

Amarin pulls a Romney: For the second time in a week, premature news of FDA drug approval posted, then retracted

There is apparently a special this week on websites posting news of drug approvals before they actually happen.

On Monday, USA Today inadvertently posted a story about the approval of Qsymia, a weight loss drug, several hours before the FDA made an announcement. Today, Amarin, which makes a compound designed to lower triglycerides, put up a site saying that the drug had been approved by the FDA. Trouble was, that decision isn’t expected until July 26. According to Reuters: Continue reading Amarin pulls a Romney: For the second time in a week, premature news of FDA drug approval posted, then retracted

USA Today posts story on approval of diet drug too soon, takes it down

USA Today has yanked back a story about a diet drug’s approval by the FDA — because the FDA hasn’t actually approved the drug yet.

The FDA is scheduled to announce its decision on the subject of the story — Vivus’ Qnexa — today. The decision has been closely watched.

The story, headlined “New diet drug helps heavy patients lose 10% of weight,” includes a lot of reporting, including comments from the president of Vivus about a change in name from Qnexa to something else. (We’ll leave USA Today that apparent scoop, although others might not.) It was posted on the Salem, Oregon’s Statesman Journal at 12:16 p.m. today, presumably Eastern, since it was taken down before the West Coast arrived at 2 p.m. Continue reading USA Today posts story on approval of diet drug too soon, takes it down